Fig. 5
![Fig. 5](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12935-021-02163-9/MediaObjects/12935_2021_2163_Fig5_HTML.png)
Identification of the independent prognostic factors in the training and validation group. A Univariate Cox analyses of the signature-based risk score and clinicopathological parameters in the training group. B Multivariate Cox analyses of the signature-based risk score and clinicopathological parameters in the training group. C Univariate Cox analyses of the signature-based risk score and clinicopathological parameters in the validation group. D Multivariate Cox analyses of the signature-based risk score and clinicopathological parameters in the validation group. E Prognostic nomogram for melanoma patients. F–G Calibration curves for the nomogram at 1-, and 3-year